Studies

CellWell record HH-343862

Lipoprotein(a) as a Cardiovascular Risk Factor: Clinical Significance and Therapeutic Perspectives

Michał Miszczak; Paweł Piwowarczyk; Grzegorz Sobieszek; Piotr Dobrowolski; Aleksander Prejbisz

2026

In plain language

Elevated lipoprotein(a) increases cardiovascular risk independent of low-density lipoprotein cholesterol; novel therapies reduced lipoprotein(a) levels by up to ninety percent.

Evidence
Emerging
Design
Expert review

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-343862

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.